Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Inflammatory Intestinal Diseases|December 15, 2023
Effectiveness and Factors Associated with Response to Golimumab in Japanese Patients with Ulcerative Colitis in Real Clinical Practice: The Phoenix StudyDaisuke Hirayama, Satoshi Motoya, Toshifumi Ashida, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|June 19, 2021
Absent X-linked inhibitor of apoptosis protein expression in T cell blasts and causal mutations including non-coding deletionShimaa Said Mohamed Ali Abdrabou, Nariaki Toita, Shin Ichihara, et al.
Inflammatory Intestinal Diseases|June 30, 2026
Short- and Long-Term Effectiveness and Safety of Vedolizumab in Crohn's Disease: A Multicenter Retrospective Study from the Hokkaido Phoenix CohortShinsuke Otagiri, Keiya Aoyama, Takehiko Katsurada, et al.
Journal of Gastroenterology|April 8, 2004
Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotypeJiro Watari, Yusuke Saitoh, Mikihiro Fujiya, et al.
Inflammatory Bowel Diseases|October 12, 2011
Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's diseaseToshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, et al.
Biomed Research International|December 28, 2013
Infliximab extends the duration until the first surgery in patients with Crohn's diseaseAki Sakatani, Mikihiro Fujiya, Takahiro Ito, et al.
BMJ Case Reports|December 14, 2011
A case of small cell carcinoma of the oesophagus treated with endoscopic mucosal resection who remained in clinical remission for 18 months: its endoscopic features with specific light spectraToshie Nata, Mikihiro Fujiya, Hiroki Tanabe, et al.
Crohn'S & Colitis 360|May 7, 2024
Effectiveness and Persistency of Ustekinumab Treatment for Ulcerative Colitis: A Phoenix retrospective Cohort StudyKatsuyoshi Ando, Mikihiro Fujiya, Nobuhiro Ueno, et al.
Gastrointestinal Endoscopy|April 29, 2008
Transnasal ultrathin endoscopy for placement of a long intestinal tube in patients with intestinal obstructionRyu Sato, Jiro Watari, Hiroki Tanabe, et al.
Journal of Gastroenterology|April 23, 2013
C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's diseaseToshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, et al.
Pageof 5